Furthermore, the DELCODE study reported lower CSF-Aβ42 levels and lower CSF-Aβ42/tau ratios in SCD patients than in healthy controls, while total tau and p-tau-181 levels were not elevated in the SCD group [42]. The gene discussed is MAPT; the disease is Schnyder corneal dystrophy.